Comunicados de prensa Newsfile Corp (Canada) — Biotechnology Salud y ciencias de la vida — Feed RSS y monitoreo en vivo
PPN World sigue el feed RSS de Newsfile Corp (Canada) — Biotechnology en tiempo real — 52 comunicados indexados en los últimos 30 días (unos 1,7 al día), el más reciente llegó hace 3 d. Síguelo con alertas de búsquedas guardadas, resúmenes con IA y búsqueda de texto completo, o conecta la URL RSS de abajo a tu propio lector.
Sobre este feed
Newsfile Corp (Canada) — Biotechnology forma parte de los más de 1,400 feeds de comunicados que PPN World monitorea de forma continua — una fuente en inglés centrada en el sector Salud y ciencias de la vida, clasificada bajo «Canadá» en nuestro índice por país. Cada comunicado se deduplica, se geolocaliza y se enriquece con un resumen de IA, y puedes añadir alertas de búsquedas guardadas sobre cualquier palabra clave que publique. En los últimos 30 días, Newsfile Corp (Canada) — Biotechnology ha publicado 52 comunicados — unos 1,7 al día, sobre todo los martes.
Sigue Newsfile Corp (Canada) — Biotechnology en tiempo real en PPN World
Cada comunicado de Newsfile Corp (Canada) — Biotechnology llega al cockpit segundos después de publicarse — deduplicado, clasificado, con alertas de búsquedas guardadas y resúmenes con IA, junto a más de 1,400 feeds. Prueba gratis de 72 h, sin tarjeta.
Iniciar la prueba gratis →Últimos comunicados de Newsfile Corp (Canada) — Biotechnology
- MustGrow Receives First Milestone Payment from Bayer AGhace 2 d
Bayer AG has paid MustGrow the first development milestone payment. The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow's mustard…
- Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000hace 3 d
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its intenti…
- iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weekshace 3 d
Woburn, Massachusetts--(Newsfile Corp. - August 20, 2026) - iSpecimen, (NASDAQ: ISPC) a provider of human biospecimens, recently completed an international cancer research project involving hundreds o…
- Hemostemix Commercializes Its Vascular Dementia Clinical Trial of VesCell(TM) Under LARTAhace 3 d
Leading cognitive-disorders specialist, Dr. William Shankle, will discuss vascular cognitive impairment, vascular dementia and the proposed clinical trial of VesCell™ (ACP-01) today at 12:00 EST, at h…
- Maxwell Biosciences' Spinout SHU.ai Announces Closing of $1M Financing Roundhace 3 d
Austin, Texas--(Newsfile Corp. - August 20, 2026) - Maxwell Biosciences, a global health technology company pioneering a new category of immune-inspired small molecules called Claromers®, December 5,…
- TempraMed Announces Extension of Maccabi Healthcare Services Agreementhace 3 d
Toronto, Ontario--(Newsfile Corp. - August 20, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator focused on tempe…
- TempraMed Announces Extension of Maccabi Healthcare Services Agreementhace 3 d
Toronto, Ontario--(Newsfile Corp. - August 20, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (OTCQB: TMPTF) (FSE: 9DY) ("TempraMed" or the "Company"), a medical technology innovator focused on tempe…
- Marvel Biosciences Expands Private Placement to Quebechace 4 d
Calgary, Alberta--(Newsfile Corp. - August 19, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") announces that it is expanding its previously announced private…
- Marvel Biosciences Expands Private Placement to Quebechace 4 d
Calgary, Alberta--(Newsfile Corp. - August 19, 2026) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) ("Marvel" or the "Company") announces that it is expanding its previously announced private…
- Illumisoft Appoints Ehsan Agahi as CEO, Commences Trading on OTCQB Venture Market, Announces Shares for Debt Settlementhace 4 d
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") today announced that Ehsan Agahi, currently Execu…
- Illumisoft Appoints Ehsan Agahi as CEO, Commences Trading on OTCQB Venture Market, Announces Shares for Debt Settlementhace 4 d
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - Illumisoft Lighting Corp. (TSXV: UVC) (OTCQB: FUVCF) ("Illumisoft" or the "Company") today announced that Ehsan Agahi, currently Execu…
- Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporationhace 4 d
Encinitas, California--(Newsfile Corp. - August 19, 2026) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora") today announced that it has licensed the development and commercialization rights for K…
Los comunicados más recientes de esta fuente se transmiten en vivo para los miembros de PPN World.
Preguntas frecuentes
¿Cómo seguir los comunicados de Newsfile Corp (Canada) — Biotechnology en tiempo real?+
¿Con qué frecuencia se recogen los comunicados de Newsfile Corp (Canada) — Biotechnology?+
¿Qué tipo de comunicados publica Newsfile Corp (Canada) — Biotechnology?+
Feeds relacionados
- Newsfile Corp (Canada) — All Releases
- Newsfile Corp (Canada) — Mining & Metals
- Newsfile Corp (Canada) — Cannabis
- Newsfile Corp (Canada) — Technology
- Newsfile Corp (Canada) — Energy
- Newsfile Corp (Canada) — Aerospace & Defence
- Newsfile Corp (Canada) — Fil français
- Statistics Canada — The Daily: Health
- PR Newswire (Canada) — All Releases
- PR Newswire (Canada) — Financial Services